Retraction
Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity
Paper Information
Record ID:
41375
Author(s):
Journal:
Publication Date:
December 01, 2017
Retraction Date:
December 17, 2022
(2.9 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Impact Journals
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (12)
12
Total Citations3
Post-Retraction(25.0%)
9
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
1
After 2+ years
731
Days since retraction (latest)
The possible anti-tumor effects of regulatory T cells plasticity / IL-35 in the tumor microenvironment of the major three cancer types
Rehab G. Khalil, Dina Mostafa Mohammed, Hadeer M. Hamdalla et al. (4 authors)
Cytokine
Published: Dec 2024
3 citations
3 citations
731 days after retraction
A glance on the role of IL-35 in systemic lupus erythematosus (SLE)
Davood Bahadorian, Tola Abdulsattar Faraj, Ramiar Kamal Kheder et al. (7 authors)
Cytokine
Published: Jan 2024
5 citations
5 citations
409 days after retraction
IL-35: New Target for Immunotherapy Targeting the Tumor Microenvironment
Pengcheng Yi, Wenjun Yu, Yanhong Xiong et al. (8 authors)
Molecular Cancer Therapeutics
Published: Nov 2023
13 citations
13 citations
339 days after retraction
Targeting T regulatory cells: Their role in colorectal carcinoma progression and current clinical trials
Sai Samyuktha Bandaru, Rajendra Boyilla, Neha Merchant et al. (5 authors)
Pharmacological Research
Published: Mar 2022
9 citations
9 citations
263 days before retraction
Correlation and prognostic implications of intratumor and tumor draining lymph node Foxp3+ T regulatory cells in colorectal cancer
Bing Yan, Jianmei Xiong, Qianwen Ye et al. (8 authors)
BMC Gastroenterology
Open Access
Published: Mar 2022
3 citations
3 citations
276 days before retraction
IL-35 Regulates the Function of Immune Cells in Tumor Microenvironment
Kewei Liu, Ai Huang, Jun Nie et al. (7 authors)
Frontiers in Immunology
Open Access
Published: May 2021
50 citations
50 citations
575 days before retraction
IL-12 Family Cytokines in Cancer and Immunotherapy
Bhalchandra Mirlekar, Yuliya Pylayeva‐Gupta
Cancers
Open Access
Published: Jan 2021
224 citations
224 citations
710 days before retraction
IL35 predicts prognosis in gastric cancer and is associated with angiogenesis by altering TIMP1, PAI1 and IGFBP1
Xiao Li, Nan Niu, Jing Sun et al. (6 authors)
FEBS Open Bio
Open Access
Published: Oct 2020
13 citations
13 citations
792 days before retraction
Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
Jialin Zhu, Yan Wang, Li Dai et al. (6 authors)
Cancer Cell International
Open Access
Published: Oct 2020
20 citations
20 citations
801 days before retraction
IL‐35, a double‐edged sword in cancer
Zahra Yazdani, Alireza Rafiei, Monireh Golpour et al. (6 authors)
Journal of Cellular Biochemistry
Published: Oct 2019
39 citations
39 citations
1153 days before retraction
Interleukin-35 suppresses antitumor activity of circulating CD8<sup>+</sup> T cells in osteosarcoma patients
Ming-Xi Liu, Qingyu Liu, Ye Liu et al. (7 authors)
Connective Tissue Research
Published: Jan 2019
16 citations
16 citations
1440 days before retraction
Increased IL-33 and IL-17 in Colorectal Carcinoma Patients with Severe Disease
Veljko Marić, Marina Jovanović, Nataša Zdravković et al. (8 authors)
Serbian Journal of Experimental and Clinical Research
Open Access
Published: Dec 2018
2 citations
2 citations
1458 days before retraction
Quick Stats
Total Citations:
12
Years Since Retraction:
2.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025